BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

969 related articles for article (PubMed ID: 12717232)

  • 41. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
    Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of allergic conjunctival inflammation on the allogeneic response to donor cornea.
    Flynn TH; Ohbayashi M; Ikeda Y; Ono SJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4044-9. PubMed ID: 17724186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Graft rejection by T cells not restricted by conventional major histocompatibility complex molecules.
    Dierich A; Chan SH; Benoist C; Mathis D
    Eur J Immunol; 1993 Oct; 23(10):2725-8. PubMed ID: 8104801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
    Niederkorn JY; Mayhew E; Mellon J; Hegde S
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice.
    Benichou G; Valujskikh A; Heeger PS
    J Immunol; 1999 Jan; 162(1):352-8. PubMed ID: 9886406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The significance of gender incompatibility in donors and recipients and the role of minor histocompatibility antigens in corneal transplantation].
    Hasková Z; Filipec M; Holán V
    Cesk Slov Oftalmol; 1997 May; 53(2):128-35. PubMed ID: 9296861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
    Wecker H; Grusby MJ; Auchincloss H
    Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
    [No Abstract]   [Full Text] [Related]  

  • 49. In vivo study of T-cell responses to skin alloantigens in Xenopus using a novel whole-mount immunohistology method.
    Ramanayake T; Simon DA; Frelinger JG; Lord EM; Robert J
    Transplantation; 2007 Jan; 83(2):159-66. PubMed ID: 17264812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody.
    Rosenberg AS; Finbloom DS; Maniero TG; Van der Meide PH; Singer A
    J Immunol; 1990 Jun; 144(12):4648-50. PubMed ID: 2112572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
    Hori J; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
    Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
    Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of T cells with differential responses to alloantigens in CD45 exon 6-deficient mice.
    Kong YY; Kishihara K; Yoshida H; Mak TW; Nomoto K
    J Immunol; 1995 Jun; 154(11):5725-35. PubMed ID: 7751624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection.
    Nicholls SM; Bradley BB; Easty DL
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2729-34. PubMed ID: 1894472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival of MHC-deficient mouse heterotopic cardiac allografts.
    Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
    Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice.
    Peeler J; Niederkorn J; Matoba A
    Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1516-23. PubMed ID: 2414248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of alloreactive T cell subpopulations of aged mice in vivo. CD4+ but not CD8+ T cell-mediated rejection response declines with advanced age.
    Rosenberg AS; Sechler JM; Horvath JA; Maniero TG; Bloom ET
    Eur J Immunol; 1994 Jun; 24(6):1312-6. PubMed ID: 7911422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
    Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
    J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody.
    He YG; Ross J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2723-8. PubMed ID: 1680112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.